|
mutLBSgeneDB |
| |
| |
| |
| |
| |
| |
|
| Gene summary for CELF1 |
 Gene summary |
| Basic gene Info. | Gene symbol | CELF1 |
| Gene name | CUGBP, Elav-like family member 1 | |
| Synonyms | BRUNOL2|CUG-BP|CUGBP|CUGBP1|EDEN-BP|NAB50|NAPOR|hNab50 | |
| Cytomap | UCSC genome browser: 11p11 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001025596.2, NM_001172639.1,NM_001172640.1,NM_006560.3,NM_198700.2, | |
| Description | 50 kDa nuclear polyadenylated RNA-binding proteinCELF-1CUG RNA-binding proteinCUG triplet repeat RNA-binding protein 1CUG triplet repeat, RNA binding protein 1CUG triplet repeat, RNA-binding protein 1CUG-BP- and ETR-3-like factor 1CUG-BP1CUGBP Ela | |
| Modification date | 20141207 | |
| dbXrefs | MIM : 601074 | |
| HGNC : HGNC | ||
| Ensembl : ENSG00000149187 | ||
| HPRD : 03046 | ||
| Protein | UniProt: Q92879 go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_CELF1 | |
| BioGPS: 10658 | ||
| Pathway | NCI Pathway Interaction Database: CELF1 | |
| KEGG: CELF1 | ||
| REACTOME: CELF1 | ||
| Pathway Commons: CELF1 | ||
| Context | iHOP: CELF1 | |
| ligand binding site mutation search in PubMed: CELF1 | ||
| UCL Cancer Institute: CELF1 | ||
| Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. | |
| Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO Term | PubMed ID | GO:0043484 | regulation of RNA splicing | 16946708 |
| Top |
| Ligand binding site mutations for CELF1 |
| Lollipop-style diagram of mutations at LBS in amino-acid sequence. We represented ligand binding site mutations only. (You can see big image via clicking.)  : non-synonymous mutation on LBS, Circle size denotes number of samples. |
 |
| Cancer type specific mutLBS sorted by frequency |
| LBS | AAchange of nsSNV | Cancer type | # samples | K117 | K117N | BRCA | 1 | R25 | P24S | HNSC | 1 | R49 | R49M | LUAD | 1 | R49 | R49T | LUSC | 1 | A97 | A97P | OV | 1 | K184 | A186V | UCEC | 1 | R478 | S479L | UCEC | 1 |
| cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
| Top |
| Protein structure related information for CELF1 |
| Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
 : nsSNV at non-LBS : nsSNV at LBS |
 |
| nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
| LBS | AAchange of nsSNV | Relative stability change | K117 | K117N | -1.1792328 | R49 | R49T | -1.1391495 | K184 | A186V | -0.88265464 | R49 | R49M | -0.84541671 | R25 | P24S | -0.84295118 | R478 | S479L | -0.79858079 | A97 | A97P | -0.54439227 |
| (MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
| Structure image for CELF1 from PDB |
| Top |
| Differential gene expression and gene-gene network for CELF1 |
| Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
| Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
| Top |
| Top |
| Phenotype information for CELF1 |
| Gene level disease information (DisGeNet) |
| Disease ID | Disease name | # PubMed | Association type |
| Mutation level pathogenic information (ClinVar annotation) |
| Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
| Top |
| Pharmacological information for CELF1 |
| Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
 |
| Drug information targeting mutLBSgene (Approved drugs only) |
| Drug status | DrugBank ID | Name | Type | Drug structure |
| Gene-centered ligand-gene interaction network |
 |
| Ligands binding to mutated ligand binding site of CELF1 go to BioLip |
| Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | NUC | Nucleic Acids | 3nnh | C | A97 | NUC | Nucleic Acids | 3nnh | B | A97 | NUC | Nucleic Acids | 3nnc | A | K117 K184 | NUC | Nucleic Acids | 3nmr | A | K184 | NUC | Nucleic Acids | 3nna | A | K184 | NUC | Nucleic Acids | 3nnh | D | R25 A97 | NUC | Nucleic Acids | 3nnh | A | R25 R49 | NUC | Nucleic Acids | 2rqc | A | R478 |
| Top |
| Conservation information for LBS of CELF1 |
| Multiple alignments for Q92879 in multiple species |
| LBS | AA sequence | # species | Species |
 |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |